La survie des cellules cancéreuses dépend d’une activité énergétique et biosynthétique accrue et la glutamine participe à de nombreux processus nécessaires à cette adaptation métabolique. Dans les leucémies aiguës myéloïdes (LAM), la croissance et la prolifération sont favorisées par l’activation anormale de plusieurs voies de signalisation, et notamment par la voie mTORC1. Les acides aminés essentiels, et en particulier la leucine, sont indispensables à l’activation de mTORC1. La glutamine est captée par la cellule via le transporteur SLC1A5 et permet ensuite l’entrée de la leucine via le transporteur bidirectionnel SLC7A5. La concentration en glutamine est donc une étape limitante dans l’activation de mTORC1 par la leucine. Nous avons étudié les effets de la privation en glutamine dans les LAM à l’aide de différents outils (milieu sans glutamine, shARN inhibant l’expression du transporteur de la glutamine SLC1A5 et la drogue L-asparaginase, qui a une activité de glutaminase extracellulaire), et observé une inhibition de mTORC1 et de la synthèse protéique. L’inhibition du transporteur SLC1A5 inhibe la pousse tumorale dans un modèle de xénotransplantation. La L-asparaginase inhibe mTORC1 et induit une apoptose de façon proportionnelle à son activité glutaminase et complètement indépendante de la concentration en asparagine. La privation en glutamine induit l’expression de la glutamine synthase et l’autophagie, et ces deux processus peuvent être des mécanismes de résistance intrinsèques ou acquis dans certaines lignées leucémiques. L’apoptose induite par la privation en glutamine n’est cependant pas liée à l’inhibition de mTORC1, puisqu’elle n’est pas diminuée par l’utilisation d’un mutant de mTOR non inhibé par la privation en glutamine. Nous nous sommes donc intéressés à une autre voie dépendante de la glutamine dans de nombreux cancers, la phosphorylation oxydative. L’étape initiale du catabolisme intracellulaire de la glutamine est la conversion de la glutamine en glutamate par des enzymes appelées glutaminases. Différentes isoformes des glutaminases existent qui sont codées chez l’homme par les gènes GLS1 et GLS2. Le glutamate est ensuite transformé en α-cétoglutarate, intermédiaire du cycle TCA. Dans les lignées de LAM, la privation en glutamine inhibe la phosphorylation oxydative mitochondriale. Nous avons observé que la protéine glutaminase C (GAC), une des isoformes de GLS1, est constamment exprimée dans les LAM mais aussi dans les progéniteurs hématopoïétiques CD34+ normaux. L’inhibition d’expression de la GLS1 par des shARN inductibles ou bien par le composé CB-839 réduit la phosphorylation oxydative, conduisant à une inhibition de prolifération et à une induction d’apoptose des cellules leucémiques. L’invalidation génétique de la GLS1 inhibe la formation de tumeur et améliore la survie des souris dans un modèle de xénotransplantation. A l’inverse, le ciblage de la GLS1 n’a pas d’effets cytotoxiques ni cytostatiques sur les progéniteurs hématopoïétiques normaux. Ces effets anti-leucémiques sont inhibés par l’adjonction d’α-cétoglutarate, et ceux induit par le CB-839 sont abrogés lorsqu’est exprimé de façon ectopique un mutant GACK320A hyperactif, attestant du rôle essentiel du maintien d’un cycle TCA actif dans les cellules de LAM. Enfin, nous montrons que l’inhibition de la glutaminolyse active la voie d’apoptose mitochondriale intrinsèque et agit en synergie avec l’inhibition spécifique de BCL-2 par l’ABT-199. Ces résultats démontrent que le ciblage spécifique de la glutaminolyse est une autre façon d’exploiter l’addiction à la glutamine des cellules leucémiques de LAM et que le maintien d’un cycle TCA actif est essentiel à la survie de ces cellules. / Cancer cells survival is dependent on high energetic and biosynthetic activity, and glutamine is involved in many metabolic processes necessary for this adaptation. In acute myeloid leukemia (AML), growth and proliferation are promoted by activation of several signaling pathways, including mTORC1. Essential amino acids, in particular leucine, are required for mTORC1 activation. Glutamine enters into the cell via the SLC1A5 transporter and then allows the input of leucine via the bidirectional SLC7A5 transporter. Therefore, the intracellular glutamine concentration is a limiting step in the activation of mTORC1 by leucine. We studied the effects of glutamine deprivation in AML using different tools (medium without glutamine, shRNA against the SLC1A5 glutamine transporter and the drug L-asparaginase, which has an extracellular glutaminase activity) and observed mTORC1 and protein synthesis inhibition. SLC1A5 transporter knockdown inhibits tumor growth in a xenotransplantation model. L-asparaginase inhibits mTORC1 and induces apoptosis in proportion to its glutaminase activity and independently of asparagine concentration. Glutamine privation induces the expression of glutamine synthase and autophagy, and these two processes are involved in the resistance to glutamine privation in some leukemic cell lines. However, apoptosis induced by glutamine privation is not related to the inhibition of mTORC1, since it is not modified in the presence of a constitutively active mutant of mTOR. We next focused on the oxidative phosphorylation, another glutamine dependent pathway in many cancers. The initial step of the intracellular catabolism of glutamine is the conversion of glutamine to glutamate by enzymes called glutaminases. Different glutaminases isoforms exist that are encoded by the GLS1 and GLS2 genes. Glutamate is then converted to α-ketoglutarate, an essential TCA cycle intermediate. In AML cell lines, we observed that glutamine privation inhibits mitochondrial oxidative phosphorylation. The protein glutaminase C (GAC), an isoform of GLS1, is constantly expressed in AML but also in normal CD34 + hematopoietic progenitors. The knockdown of GLS1 by inducible shRNA or by the CB-839 compound reduced oxidative phosphorylation, leading to proliferation inhibition and apoptosis induction in leukemia cells. Genetic invalidation of GLS1 inhibits tumor formation and improves survival of mice in a xenograft model. Conversely, the targeting of GLS1 has no cytotoxic or cytostatic effects on normal hematopoietic progenitors. These anti-leukemic effects are inhibited by the addition of α-ketoglutarate, and those induced by the CB-839 are suppressed in the presence of an ectopically expressed GACK320A hyperactive mutant, confirming the essential role of maintaining an active TCA cycle in AML cells. Finally, we showed that glutaminolysis inhibition induces the intrinsic mitochondrial pathway of apoptosis and acts synergistically with the specific inhibition of BCL-2 by ABT-199. These results demonstrate that specific targeting of glutaminolysis is another way to exploit glutamine addiction in AML and that an active TCA cycle in essential for AML cell survival.

Cette étude vise à estimer l’apport en glutamine (Gln) alimentaire chez des athlètes soumis à un protocole de supplémentation en glutamine ainsi qu’à clarifier les informations diffusées au grand public en ce qui concerne les sources alimentaires de glutamine. Des études cliniques ont démontré que la supplémentation en glutamine pouvait réduire la morbidité et la mortalité chez des sujets en phase critique (grands brulés, chirurgie…). Le mécanisme en cause semble impliquer le système immunitaire. Cependant, les études chez les sportifs, dont le système immunitaire a de fortes chances d’être affaibli lors de périodes d’entraînement prolongées impliquant des efforts longs et intenses, n’ont pas été concluantes. Or, ces études négligent systématiquement l’apport alimentaire en glutamine, si bien qu’il est probable que les résultats contradictoires observés puissent en partie être expliqués par les choix alimentaires des sujets. Puisque la méthode conventionnelle de dosage des acides aminés dans les protéines alimentaires transforme la glutamine en glutamate, les tables de composition des aliments présentent la glutamine et le glutamate ensemble sous la dénomination « glutamate » ou « Glu », ce qui a comme conséquence de créer de l’ambiguïté. La dénomination « Glx » devrait être utilisée. Partant de la probabilité qu’un apport en Glx élevé soit un bon indicateur de l’apport en glutamine, nous avons créé un calculateur de Glx et avons évalué l’alimentation de 12 athlètes faisant partie d’une étude de supplémentation en glutamine. Nous avons alors constaté que l’apport en Glx était directement proportionnel à l’apport en protéines, avec 20,64 % ± 1,13 % de l’apport protéique sous forme de Glx. Grâce à quelques données sur la séquence primaire des acides aminés, nous avons pu constater que le rapport Gln/Glx pouvait être très variable d’un type de protéine à l’autre. Alors que le ratio molaire Gln/Glx est de ~95 % pour les α et β-gliadines, il n’est que de ~43 % pour la caséine, de ~36 % pour la β-lactoglobuline, de ~31 % pour l’ovalbumine et de ~28 % pour l’actine. Il est donc possible que certaines protéines puissent présenter des avantages par rapport à d’autres, à quantité égale de Glx. / The purpose of this study is to estimate the dietary glutamine (Gln) intake of subjects undertaking a glutamine supplementation protocol and to clarify the information about the glutamine content of food products. Clinical studies have demonstrated that glutamine supplementation can reduce mortality and morbidity associated with critical illness and that the mechanism underneath may imply the immune system. Studies undertaken on elite athletes, who may experience a drop in immune defence subsequent to long and strenuous training, have not been conclusive at this time. Yet, these studies systematically do not take glutamine intake from food into consideration in such a way that the conflicting results observed could have something to do with the food choices of the subjects. Since the conventional method used for the analysis of the amino acids content in food converts glutamine into glutamate, the food databases present glutamine and glutamate under the denomination “glutamate” or “Glu”. However, the term “Glx” should be used. Based on the probability that a high Glx intake could be a good indicator of glutamine intake, we have created a Glx calculator and have used it to analyse the food diaries of 12 athletes who participated in a study on glutamine supplementation. We observed that Glx intake was directly proportional to protein intake with 20,64 % ± 1,13 % of protein intake being Glx. Using data from the primary structure of amino acids, we observed that different types of protein showed a wide range of Gln/Glx ratios. While α and β-gliadins present a molar ratio of Gln/Glx of ~95 %, this ratio drops to 43 % for casein, 36 % for β-lactoglobulin, 31 % for ovalbumin and 28 % for actins. It is thus possible that certain types of protein can present advantages with regard to others, Glx remaining constant.

Les thérapies anti-tumorales se sont considérablement améliorées au cours de la dernière décennie. Toutefois, les traitements utilisés actuellement rencontrent d'importantes limitations, notamment dans le cas de cancers métastatiques, révélant l'urgence de développer de nouvelles approches. Ainsi, l'immunothérapie par transfert adoptif de cellules T représente une approche innovante particulièrement prometteuse. Son principe s'appuie sur l'injection de cellules T autologues spécifiques d'antigènes tumoraux, préalablement manipulées et amplifiées ex vivo, chez des patients rendus lymphopéniques par chimiothérapie et/ou radiothérapie. Toutefois, même si l'état lymphopénique est induit par ces 2 protocoles de conditionnements, leurs effets sur l'environnement de l'hôte ainsi que sur le devenir des cellules T greffées étaient, jusqu'à nos travaux, mal connus. Par le biais de modèles murins, nous avons pu démontrer que le devenir des cellules T diffère après transfert dans des souris irradiées ou traitées par chimiothérapie (Bu/Cy). Ainsi, après transfert dans des animaux irradiés, on observe une prolifération préférentielle des cellules T CD8, dépendante de l'IL-7, est observée alors qu'un transfert chez des souris traitées Bu/Cy se traduit par une prolifération rapide, indépendante de l'IL-7, des cellules T CD4. De plus, ces comportements sont associés à d'importantes modifications de l'environnement généré chez l'hôte. Plus spécifiquement, nous avons démontré, dans les organes lymphoïdes secondaires, que la localisation et la représentation des différentes sous-populations de cellules dendritiques présentes étaient différentiellement modulées par le type de conditionnement utilisé. Par ailleurs, l'élimination spécifique des cellules CD11c+ chez des souris traitées Bu/Cy était accompagnée d'une inhibition importante de la prolifération rapide des cellules T CD4 greffées. L'ensemble de nos travaux montrent que les traitements lymphopéniques génèrent des environnements distincts capables de moduler le devenir des cellules T greffées.Durant ma thèse, nous avons également abordé de façon originale un aspect novateur de l'environnement en étudiant le rôle potentiel des nutriments comme régulateurs métaboliques des fonctions effectrices des cellules T. La glutamine est l'acide aminé le plus abondant du plasma, pouvant contribuer aux besoins bionénergétiques et biosynthétiques des cellules T en prolifération. Nous avons démontré dans nos travaux qu'une carence en glutamine lors de l'activation de cellules T CD4 par leur TCR entrainait un délai dans l'activation de la voie mTOR, une réduction de la production intracellulaire d'ATP aux temps précoces et se traduisait par une diminution de la prolifération. De plus, ces conditions étaient associées à une augmentation de la conversion de cellules CD4 T naïves, via TGFβ, en cellules régulatrices Foxp3+ , y compris en condition de polarization Th1. Par contre, la carence en glutamine n'a pas inhibé la différenciation Th2. Les cellules T Foxp3+ ainsi générées en condition limitante de glutamine présentaient in vivo des fonctions suppressives aussi efficaces que celles des cellules régulatrices nTregs. En effet, elles ont la capacité de bloquer l'induction de la colite provoquée par la greffe de cellules T effectrices dans des souris Rag2-/- . Nos travaux démontrent ainsi que l'environnement métabolique peut être un régulateur clé de la différenciation des cellules T CD4. L'ensemble de mes travaux de thèse ont mis en évidence de nouveaux paramètres capables de potentiellement modifier la survie et la réactivité des cellules T greffées. / Anti-tumor therapies have improved significantly over the decade. However, the currently used treatments have important limitations, notably for metastatic cancers, and the development of new approaches is therefore a high priority. Adoptive T cell therapy (ACT) represents an innovative strategy that has shown much promise. This therapy is based on the infusion of tumor-specific T cells, which have been manipulated and expanded ex vivo, into patients who have been rendered lymphopenic by chemotherapy and/or irradiation. It is interesting to note that while lymphodepletion is attained by the vast majority of conditioning regimens, the effects of these protocols on the host environment and potentially, on the destiny of adoptively-transferred T cells had not been elucidated prior to the studies which we initiated. Using a murine model, we found that the fate of adoptively-transferred T cells differs markedly in mice rendered lymphopenic by sub-lethal irradiation as compared to a busulfan/cyclophosphamide (Bu/Cy) chemotherapy regimen. Irradiation-mediated lymphopenia resulted in a skewed IL-7-dependent proliferation of donor CD8+ T cells, whereas Bu/Cy treatment led to an increased IL-7-independent, rapid CD4+ T cell proliferation. These alterations in T cell proliferation were associated with striking changes in the host microenvironment. More specifically, we demonstrated that the proportion and localization of different dendritic cell (DC) subsets in lymphoid organs were differentially affected by the type of conditioning. Furthermore, we found that these DC controlled the rapid donor CD4+ T cell division detected in Bu/Cy-treated mice as depletion of CD11c+ DC inhibited this proliferation. Altogether, our studies demonstrate that lymphopenic regimens generate distinct host environments which modulate the fate of adoptively-transferred T cells. Durind my PhD, we also investigated an original and novel aspect of the microenvironement by studying the potential role of nutrients as metabolic regulators of T cell effector function. Glutamine is the most abundant amino acid in the plasma and contributes to the bioenergetic and biosynthetic requirements of proliferating T cells. Here, we demonstrated that activation of CD4+ T cells under glutamine-deprived conditions results in a delayed mTOR activation with reduced early ATP production and decreased proliferation. Moreover, these conditions resulted in the conversion of naïve CD4+ T cells into Foxp3+ regulatory T cells (Tregs). This de novo Treg differentiation occurred even under Th1-polarizing conditions and was TGFβ-dependent. Interestingly, glutamine deprivation did not inhibit Th2 differentiation. Importantly, these converted Foxp3+ T cells showed enhanced in vivo persistence and were highly suppressive, completely protecting Rag-deficient mice from the development of autoimmune inflammatory bowel disease as efficiently as natural-occuring Tregs. Thus, our data reveal the external metabolic environment to be a key regulator of a CD4 T lymphocyte's differentiation. Altogether, the data generated during my PhD provide new insights into the identification of parameters that can potentially alter the survival and reactivity of adoptively-transferred T cells.

As estratÃgias para prevenir a lesÃo de isquemia reperfusÃo durante as cirurgias hepÃticas incluem a oclusÃo intermitente do fluxo de sangue ao fÃgado ou a utilizaÃÃo de substÃncias que poderiam causar um efeito protetor ou aumento da resistÃncia do tecido hepÃtico à isquemia. O presente estudo teve o objetivo de avaliar o efeito do uso da L-Alanil-Glutamina (GLN) em Ratus novergicus submetidos à isquemia hepÃtica normotÃrmica, atravÃs de provas bioquÃmicas e imunohistoquÃmicas. Utilizou-se 30 ratos machos, da variedade Wistar, com peso mÃdio de 300 gramas, distribuÃdos em trÃs grupos de 10 ratos cada: grupo Controle, Grupo Isquemia ReperfusÃo (IR) e grupo Glutamina + Isquemia ReperfusÃo (GLN+IR). O grupo IR recebeu soluÃÃo salina 0,9% intra-peritoneal (IP), 2 horas antes de ser submetido laparotomia, e isquemia total por pinÃamento da trÃade portal por 30 minutos seguidos de reperfusÃo por 60 minutos; O grupo GLN + IR recebeu 0,75mg/Kg de glutamina IP 2 horas antes de isquemia total por 30 minutos, seguidos de reperfusÃo por 60 minutos. O grupo Controle foi submetido à punÃÃo peritoneal 2 horas antes da laparotomia, e de apenas manipulaÃÃo da trÃade portal, sem realizar pinÃamento algum. O procedimento foi realizado sob anestesia (IP) com uma soluÃÃo de cloridrato de ketamina, 80 mg/Kg + cloridrato xilazina, 10 mg/Kg. Ao final do perÃodo de reperfusÃo os animais foram relaparotomizados e colhido amostras de sangue para avaliaÃÃo dos nÃveis de ALT e DHL, e amostras de tecido hepÃtico para estudo imunohistoquÃmico com anticorpo para Caspase-3. A significÃncia estatÃstica foi calculada pelo teste ANOVA e pelo pÃs-teste de comparaÃÃo de mÃltiplas mÃdias de Tukey utilizando-se o software GraphPad Prism, versÃo 5.00. A mÃdia e erro padrÃo da dosagem de ALT, DHL, e do Ãndice de cÃlulas marcadas com Caspase-3 foi respectivamente para o grupo IR: 270,6+40,8; 2079,0+262,4 e 66,3+13,5; para o grupo GLN +IR: 127,9+31,17; 1019,0+187,9 e 36,6+12,0; para o grupo Controle: 83,3+5,5; 206,6+16,2 e 21,9+111,4. O prÃ-condicionamento com L-alanil-GLN IP reduziu significativamente os valores de ALT e DHL em Ratus novergicus, submetidos à lesÃo de IR hepÃtica, sugerindo hepatoproteÃÃo. / As estratÃgias para prevenir a lesÃo de isquemia reperfusÃo durante as cirurgias hepÃticas incluem a oclusÃo intermitente do fluxo de sangue ao fÃgado ou a utilizaÃÃo de substÃncias que poderiam causar um efeito protetor ou aumento da resistÃncia do tecido hepÃtico à isquemia. O presente estudo teve o objetivo de avaliar o efeito do uso da L-Alanil-Glutamina (GLN) em Ratus novergicus submetidos à isquemia hepÃtica normotÃrmica, atravÃs de provas bioquÃmicas e imunohistoquÃmicas. Utilizou-se 30 ratos machos, da variedade Wistar, com peso mÃdio de 300 gramas, distribuÃdos em trÃs grupos de 10 ratos cada: grupo Controle, Grupo Isquemia ReperfusÃo (IR) e grupo Glutamina + Isquemia ReperfusÃo (GLN+IR). O grupo IR recebeu soluÃÃo salina 0,9% intra-peritoneal (IP), 2 horas antes de ser submetido laparotomia, e isquemia total por pinÃamento da trÃade portal por 30 minutos seguidos de reperfusÃo por 60 minutos; O grupo GLN + IR recebeu 0,75mg/Kg de glutamina IP 2 horas antes de isquemia total por 30 minutos, seguidos de reperfusÃo por 60 minutos. O grupo Controle foi submetido à punÃÃo peritoneal 2 horas antes da laparotomia, e de apenas manipulaÃÃo da trÃade portal, sem realizar pinÃamento algum. O procedimento foi realizado sob anestesia (IP) com uma soluÃÃo de cloridrato de ketamina, 80 mg/Kg + cloridrato xilazina, 10 mg/Kg. Ao final do perÃodo de reperfusÃo os animais foram relaparotomizados e colhido amostras de sangue para avaliaÃÃo dos nÃveis de ALT e DHL, e amostras de tecido hepÃtico para estudo imunohistoquÃmico com anticorpo para Caspase-3. A significÃncia estatÃstica foi calculada pelo teste ANOVA e pelo pÃs-teste de comparaÃÃo de mÃltiplas mÃdias de Tukey utilizando-se o software GraphPad Prism, versÃo 5.00. A mÃdia e erro padrÃo da dosagem de ALT, DHL, e do Ãndice de cÃlulas marcadas com Caspase-3 foi respectivamente para o grupo IR: 270,6+40,8; 2079,0+262,4 e 66,3+13,5; para o grupo GLN +IR: 127,9+31,17; 1019,0+187,9 e 36,6+12,0; para o grupo Controle: 83,3+5,5; 206,6+16,2 e 21,9+111,4. O prÃ-condicionamento com L-alanil-GLN IP reduziu significativamente os valores de ALT e DHL em Ratus novergicus, submetidos à lesÃo de IR hepÃtica, sugerindo hepatoproteÃÃo. / The strategies to prevent the hepatic ischemia/reperfusion injury after hepatic resections or transplantation include intermittent control of blood influx to the liver or the use of a substance that could cause a protective effect or increase of the resistance of the hepatic tissue to ischemia. The present study had the objective to evaluate the effect of the use of the L-Alanil-Glutamina in Ratus novergicus submitted the normothermic hepatic ischemia on liver biochemists and imunohistochemistry, as well as evaluating apoptosis present in this experimental model. 30 male rats, with average weight of 300 grams, divided in three groups of 10 rats: Control group, Ischemia Reperfusion group and Glutamine group. Ischemia Reperfusion group received saline solution 0.9% intra-peritoneal (IP), 2 hours before being submitted to laparotomy, and total ischemia by clampping of portal triad for 30 minutes followed of reperfusion for 60 minutes; The Glutamine group received 0,75mg/Kg IP 2 hours before total ischemia for 30 minutes, followed by reperfusion for 60 minutes. Control group was submitted the peritoneal punction 2 hours before the laparotomy, and only manipulation of the biliary tree, without carrying through any clamping. The procedure was carried through under anesthesia (IP) with a solution of Ketamin chloridate , 80 mg/Kg + xilazin chloridate, 10 mg/Kg. To the end of the period of reperfusion the animals had been relaparotomized and blood collected for evaluation of the levels of ALT and DHL, and hepatic tissue samples for imunohistochemistry study with antibody for Caspase-3. The statistics significance was calculated by ANOVA and the post test of multiple comparison of Tukey, using the software GraphPad Prism, version 5.00. The average and error standard of the dosage of ALT, DHL, and of the index of cells marked with Caspase-3 was respectively for the Ischemia Reperfusion group: 270,6+40,8; 2079,0+262,4 and 66,3+13,5; for the Glutamine group: 127,9+31,17; 1019,0+187,9 and 36,6+12,0; for the Control group: 83,3+5,5; 206,6+16,2 and 21,9+111,4. The preconditioning with intraperitoneal L-alanil-glutamine significantly reduces the values of the biochemists markers, in Ratus novergicus submitted to the hepatic ischemia-reperfusion injury, suggesting hepatic protection. / The strategies to prevent the hepatic ischemia/reperfusion injury after hepatic resections or transplantation include intermittent control of blood influx to the liver or the use of a substance that could cause a protective effect or increase of the resistance of the hepatic tissue to ischemia. The present study had the objective to evaluate the effect of the use of the L-Alanil-Glutamina in Ratus novergicus submitted the normothermic hepatic ischemia on liver biochemists and imunohistochemistry, as well as evaluating apoptosis present in this experimental model. 30 male rats, with average weight of 300 grams, divided in three groups of 10 rats: Control group, Ischemia Reperfusion group and Glutamine group. Ischemia Reperfusion group received saline solution 0.9% intra-peritoneal (IP), 2 hours before being submitted to laparotomy, and total ischemia by clampping of portal triad for 30 minutes followed of reperfusion for 60 minutes; The Glutamine group received 0,75mg/Kg IP 2 hours before total ischemia for 30 minutes, followed by reperfusion for 60 minutes. Control group was submitted the peritoneal punction 2 hours before the laparotomy, and only manipulation of the biliary tree, without carrying through any clamping. The procedure was carried through under anesthesia (IP) with a solution of Ketamin chloridate , 80 mg/Kg + xilazin chloridate, 10 mg/Kg. To the end of the period of reperfusion the animals had been relaparotomized and blood collected for evaluation of the levels of ALT and DHL, and hepatic tissue samples for imunohistochemistry study with antibody for Caspase-3. The statistics significance was calculated by ANOVA and the post test of multiple comparison of Tukey, using the software GraphPad Prism, version 5.00. The average and error standard of the dosage of ALT, DHL, and of the index of cells marked with Caspase-3 was respectively for the Ischemia Reperfusion group: 270,6+40,8; 2079,0+262,4 and 66,3+13,5; for the Glutamine group: 127,9+31,17; 1019,0+187,9 and 36,6+12,0; for the Control group: 83,3+5,5; 206,6+16,2 and 21,9+111,4. The preconditioning with intraperitoneal L-alanil-glutamine significantly reduces the values of the biochemists markers, in Ratus novergicus submitted to the hepatic ischemia-reperfusion injury, suggesting hepatic protection.

La nutrition azotée des bactéries et des plantes est actuellement un sujet de grande importance, notamment pour comprendre comment améliorer les voies métaboliques aboutissant à l’assimilation de l’azote et à plus grande échelle, optimiser des apports d’engrais et augmenter le rendement des cultures. Dans ce contexte, la réaction d’amidation catalysée par la glutamine synthétase (GS), qui fixe l’ammonium (NH₄)⁺ en glutamine, est cruciale car elle est à la fois le point d’entrée de l’azote dans les végétaux, et une étape-clef du recyclage de l’azote (en particulier, NH₄⁺ photorespiratoire). Dans cette étude, nous nous sommes intéressés à la cinétique enzymatique et au mécanisme chimique de la GS. Des systèmes analytiques (HPLC, RMN , GC-MS) ont  été optimisés pour permettre la mesure de l’activité enzymatique in vitro et pour réaliser des analyses par spectrométrie de masse à ratio isotopique. Avec ces techniques, nous avons pu regarder précisément les effets isotopiques ¹²C/¹³C, ¹⁴N/¹⁵N et H₂O/D₂O (solvant) lors de la catalyse, en utilisant la GS d’E. coli et d’Arabidopsis thaliana (GS1,2). Nos résultats montrent qu’il n’y a pas d’effet isotopique ¹²C/¹³C, mais qu’il y a un fractionnement ¹⁴N/¹⁵N de »16‰. En outre, il y a un effet inverse du solvant (réaction 1.5 à 2 fois plus rapide dans D₂O).  Cela suggère que la création de la liaison C----N (amidation) est partiellement limitante (engagement catalytique de »14% seulement) et que le réseau de ponts hydrogènes dans le site actif est crucial pour déterminer la vitesse de la réaction. L’apparition d’effets ¹⁴N/¹⁵N inverses dans certaines circonstances et les effets drastiques causés par une substitution du cofacteur métallique (Mg²⁺) suggèrent en outre que l’étape d’amidation peut être réversible et que la coordination par un métal joue un rôle très important pour stabiliser les intermédiaires de la réaction, en interaction avec le solvant. Ainsi, dans son solvant naturel qu’est H₂O, la GS réalise une réaction ‘chimiquement difficile’ (barrière énergétique élevée de l’amidation) rendue possible par le clivage de l’ATP et son caractère exergonique. / Nitrogen nutrition in bacteria and plants is currently an important topic, in particular to identify key points for metabolic improvements in N assimilation and more generally, to optimize fertilization and crop yield. In such a context, the amidation reaction catalyzed by glutamine synthetase (GS), which fixes ammonium (NH₄)⁺ into glutamine, is of crucial importance since it both represents the N entry in plants and the main step of N recycling (such as photorespiratory (NH₄)⁺. Here, we examined GS kinetics and chemical mechanism. Analytical methods (HPLC, NMR, GC-MS) have been set up so as to measure in vitro activities and isotopic abundance by isotope ratio mass spectrometry. These gave access to isotope effects (¹²C/¹³C, ¹⁴N/¹⁵N et H₂O/D₂O – solvent) during catalysis, with the GS from either E. coli or A. thaliana (GS1,2). Our results show that there no ¹²C/¹³C isotope effect but there is significant ¹⁴N/¹⁵N isotope fractionation of ca. 16‰. In addition, there is an inverse solvent isotope effect (reaction 1.5 to 2 times faster in D₂O). This suggests that forming the C----N bond (amidation) is partially rate-limiting (catalytic commitment of ca. 14% only) and the H-bond network in the active site is of substantial importance for the reaction rate. The occurrence of inverse ¹⁴N/¹⁵N isotope effects under certain circumstances as well as the drastic impact of changing the metal cofactor (Mg²⁺)) indicate that the amidation step can be reversible and that the coordination by the metal plays a key role in stabilizing reaction intermediates, by interfacing the solvent. In other words, in its natural solvent H₂O, the GS catalyses an intrinsically ‘difficult’ reaction (high energy barrier of amidation) made possible by both ATP cleavage and its exergonic nature.

There are currently over 430 known SLC transporters, over 30% of which have an unknown function. Compared to other transporter gene families, the SLC genes are relatively understudied with many orphan genes. SLC transporters have a high disease relevance and can be associated with many different diseases like gout, type 2 diabetes and different forms of cancer. SLC transporters also appear to be very druggable, thus offering a rare opportunity of an underexplored gene family, that can be linked to many diseases and seem to have a general druggability with small organic molecules. This thesis is evaluating three specific SLC transporters of the SLC38 family to discover their different roles and purposes. In this project CRISPR-Cas9 is used to knockout three SLC38 transporters, called SNAT6, SNAT8 and SNAT10. The cell-line used is HEK293 cells, as they are easy to transfect and are thought to express the three genes, however it is not certain that they do express the three SNAT genes. The project aims to optimize the method for best possible transfection by trying different protocols. A literature study is done on what the future experiments of the knocked-out cells could be, including; ensuring the HEK293 cells express the three genes, controlling the effectiveness of the transfection and analyzing the result of such a transfection. To confirm that the HEK293 cells do express the three SNATs a western blot assay could be performed. RT-qPCR is found to be useful in evaluating whether the knockouts are successful, by measuring if the three SNAT transporter proteins are present or not in the knocked-out cells. A metabolic analysis study to determine the result of the knockouts is also described as a future experiment. The experimental finding was a CRISPR-Cas9 transfection method that yielded enough RNA, enabling future experiments such as RT-qPCR.

No description available.

This thesis presents applications of high resolution secondary ion mass spectrometry (NanoSIMS) analysis for stable isotope imaging in biological samples. These projects were designed to explore the potential applications of NanoSIMS analysis, and to develop protocols and novel methodologies to visualize and quantify biological processes. Working with collaborators in the UK and USA, I have applied NanoSIMS analysis to study 3 research areas, including molecule interactions, single cell metabolisms and lipid imaging in tissues. Antimicrobial peptides (AMPs) play important role in the immune system, and understanding how AMPs interact with cell membranes can provide useful information to design new therapies to control infection. The pore structures and dynamics of the interaction of AMPs with membranes has been visualized for the first time and confirmed with combined AFM and NanoSIMS analysis. A correlative backscattered electron (BSE) imaging and NanoSIMS analysis methodology has been developed to study glutamine metabolism in single cancer cells. This method enables us to measure the chemical information in specific organelles in these cells and can be widely applied to study metabolisms and to trace the uptake of labelled molecules in biological matrices. Quantitative analysis on the effects of hypoxic conditions and the PYGL gene were studied. Applying correlative BSE and NanoSIMS analysis, I also studied lipid uptake mechanisms in various mouse tissues, including brown adipose tissue, heart, intestines, liver and skeletal muscle, mainly focused on a recently discovered protein, GPIHBP1, and its function in the lipid uptake process. TRL margination was proved to depend on the GPIBP1-LPL complex, and 3 stages of lipid transport from capillary lumen to lipid droplets was also visualized by combined BSE and NanoSIMS analysis.

Dissertation (PhD)--University of Stellenbosch, 2007. / ENGLISH ABSTRACT: Sequence analysis showed that the essential glnA1 gene of Mycobacterium tuberculosis might be closely related to an actinomycetes progenitor sequence and that this sequence may have undergone duplication into other non-essential GS encoding genes in some Actinobateria, notably the mycobacteria. Also, the M. tuberculosis glnA1 sequence remains conserved throughout the evolution of M. tuberculosis. It was also shown that glnA1 is widely expressed in M. tuberculosis infected human pulmonary tissue, where M. tuberculosis might be present in altered phenotypes. These results imply that glnA1 is under selective pressure against evolutionary change. At transcriptional level it was shown that M. tuberculosis glnA1 might be expressed from two alternate promoter sites, but that these promoter sites may not be controlled by environmental nitrogen (in the form of ammonium) variation. We also showed that M. tuberculosis GS is effectively exported by M. smegmatis to the cell wall, but that GS secretion into the exogenous environment does not occur. Also, evidence has been presented which suggested that M. tuberculosis GS might be modified at the C-terminus, probably as part of a mechanism that retains GS in the cytosol. This hypothesis was further substantiated where it was demonstrated that two GS isoforms of different size (short isoform in cytosol, longer isoform in cell wall) are present in M. bovis BCG. It is unknown what causes this modification, since it couldn’t be observed in M. smegmatis, but it was suggested that it might be through the action of a cis- or trans-acting element present in proximity of the M. tuberculosis glnA1 gene. It was also shown that a cluster of genes found immediately downstream of the M. tuberculosis glnA1 sequence might be regulated in an operonic fashion under conditions of elevated environmental nitrogen concentrations. Two of the genes (glnE and glnA2) in this operon arrangement have been previously shown to be involved in nitrogen and glutamine metabolism. The function of the other gene, Rv2223c, is unknown. It was shown that Rv2223c homologs are mostly found in the mycobacteria and that it may encode an exported protease. It was hypothesised that this sequence and its adjacently located progenitor sequence, Rv2224c, might be involved in M. tuberculosis GS mediated metabolism. It was showed that over-expression of Rv2223c and Rv2224c may be toxic to E. coli and mycobacterial hosts, such as M. smegmatis, but that inhibition of transcription of these genes may be fatal to M. bovis BCG and M. tuberculosis H37Rv. It was also shown that Rv2223c is widely expressed in M. tuberculosis infected human tissue, which was comparable to that of glnA1. The results presented in this study shed more light on the distribution and transcriptional regulation of GS in mycobacteria and has identified new genes that might be involved in GS regulation. These results may present new approaches to tuberculosis control and thereby contribute to alleviate the burden of the disease. / AFRIKAANSE OPSOMMING: Genetiese en proteien volgorde analise het aangedui dat die glnA1 (kodeer vir glutamien sintetase (GS), ‘n essentiele protein) geen van Mycobacterium tuberculosis die naaste verwant is aan ‘n actinomycetes voorloper volgorde wat duplikasie ondergaan het om die ander nieessensiele GS koderende gene in sommige Actinobakterieë te vorm, veral in die mikobakterieë. Voords het die glnA1 geen geneties gekonserveerd gebly gedurende die evolusie van M. tuberculosis. Dit is ook aangetoon dat volop transkribasie van die glnA1 geen voorkom in die M. tuberculosis geïnfekteerde pulmonêre weefsel waar M. tuberculosis moontlik mag voorkom. Op transkriptionele vlak is dit aangetoon dat die M. tuberculosis glnA1 geen vanaf twee onderskeie promotors uitgedruk mag word, maar dat hierdie twee promotors nie deur variasies in die konsentrasie van stikstof (in die vorm van ammonium) in die omgewing beïnvloed word nie. Daar is ook aangedui dat M. tuberculosis GS effektief deur M. smegmatis oor die selmembraan na die selwand vervoer word, maar dat daar nie GS sekresie na die ekstrasellulêre omgewing geskied nie. Ook is bewyse gevind dat M. tuberculosis GS modifikasie aan die C-terminus mag ondergaan wat waarskynlik dien om GS beweging uit die sitosol te verhoed. Hierdie hipotese is versterk deurdat twee isoforms van verskillende grootte (klein in sitosol en groter in die selwand) gevind is in M. bovis BCG. Dit modifikasie meganisme is onbekend, maar vind moontlik nie plaas in nie-patogeniese mikobakterieë soos M. smegmatis nie en mag moontlik deur cis- of trans-werkende elemente gefasiliteer word. Daar is aangedui dat ‘n groepering van vier gene lanksaan die glnA1 lokus in ‘n operoniese meganisme gereguleer mag word onder variërende konsentrasies van stikstof in die omgewing. Dit is bekend dat twee van die gene in die operon (glnE en glnA2) betrokke in stikstof en gultamien metabolisme is. Die funksie van die ander twee gene (Rv2223c en Rv2224c) is onbekend. Daar is aangetoon dat volgordes soortgelyk aan Rv2223c beperk is tot die mikobakterieë en dat die geen ‘n protease, wat moontlik gesekreteer word vanuit die sitosol, kodeer. Daar is aangetoon dat die oor-produksie van die Rv2223c en Rv2224c proteine toksies is vir E. coli en mikobakterieë, soos M. smegmatis, maar dat transkripsie inhibisie hierdie gene dodelik is vir M. tuberculosis H37Rv en M. bovis BCG. Daar is ook angedui dat die ekspresie van hierdie gene volop verspreid is in M. tuberculosis geïnfekteerde menslike weefsel, soortgelyk aan diè van glnA1. Die resultate vervat in hierdie studie werp meer lig op die verspreiding en transkiptionele regulasie van GS in mikobakteriee en nuwe gene is ontdek wat betrokke by GS regulasie mag wees. Hierdie resultate mag bydra tot nuwe maniere om tuberkulose te bekamp en daardeur die voorkoms van die siekte te beperk.

Ce travail porte sur l'identification de la structure et des mécanismes de formation de quelques produits de Maillard non volatils, l'objectif principal étant de mieux connaître le rôle précurseur de la glutamine. Contrairement aux molécules volatiles, nos connaissances sur les composés non volatils sont assez peu étendues. De plus, la glutamine, de structure proche de celle de l'asparagine, possède deux atomes d'azote susceptibles de participer à la réaction de Maillard : l'α-amine et l'ammoniac issu de la lactamisation. Dans ce contexte, nous avons recherché, isolé et caractérisé les produits de Maillard non volatils susceptibles de se former lors du traitement thermique d'aliments riches en glutamine et en ammoniac. A l'aide de différents outils analytiques (HPLC, fluorescence, spectrométrie de masse, RMN